GridAI Technologies Corp. (GRDX)
Last updated: 2026-10-27 21:14:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
GridAI Technologies Corp. (GRDX) operates in the ELECTRIC & OTHER SERVICES COMBINED sector and is listed on NASDAQ. The stock is currently priced at $5.83, with a market capitalization of $39.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.87 to $6.93. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$39.97M | |
$5.67 | |
$6.93 | |
$1.87 | |
$5.55 | |
89.64K | |
113.44K | |
-- | |
$6.93 | |
$1.87 | |
-- | |
-- |
GridAI Technologies Corp. (GRDX) After-Hours Stock Price
GridAI Technologies Corp. (GRDX) is trading at $5.75 in after-hours trading as of 2026-10-27 20:37:00, up 3.53% ($0.20) from the regular-session close of $5.55.
After-hours trading shows how investors are pricing GRDX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
GridAI Technologies Corp. (GRDX) 7-Day Stock Price Change
Over the past seven days, GridAI Technologies Corp. (GRDX) moved from $4.22 to $5.83, representing a gain of 38.08% ($1.61).
The stock traded between $4.14 and $5.88 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 113.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
GRDX 52-Week Price Position
Position in Range: 78.2%
GRDX is currently trading at $5.83, placing it 78.2% of the way from its 52-week low of $1.87 to its 52-week high of $6.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is GridAI Technologies Corp. (GRDX)?
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
GridAI Technologies Corp. Information
| Industry | ELECTRIC & OTHER SERVICES COMBINED |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy GridAI Technologies Corp. (GRDX) Stock on MEXC
Eligible investors can buy real shares of GridAI Technologies Corp. (GRDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is GridAI Technologies Corp. (GRDX) stock price today?
2.Is GRDX stock going up or down today?
3.What is GRDX pre-market price?
4.What is GRDX after-hours price?
5.Is GRDX stock trading now?
6.Where does GRDX sit relative to its 52-week high and low?
7.What sector is GridAI Technologies Corp. in?
8.What is GridAI Technologies Corp.'s market capitalization and where is it listed?
9.How is GRDX valued in terms of P/E ratio and EPS?
10.Does GridAI Technologies Corp. pay a dividend?
Explore More US Stocks
Search Stocks
GRDX Stock Calculator
Estimate the value between GRDX shares and USD.
GRDX Shares to USD
1.00 GRDX shares = 5.827 USD
Calculations are estimates based on the latest available price and are for reference only.



